Killer Ig-like receptor (KIR) compatibility plays a role in the prevalence of acute GVHD in unrelated hematopoietic cell transplants for AML

被引:29
作者
Sun, JY
Gaidulis, L
Dagis, A
Palmer, J
Rodriguez, R
Miller, MM
Forman, SJ
Senitzer, D
机构
[1] City Hope Natl Med Ctr, Div Hematol & HCT, Duarte, CA 91010 USA
[2] Beckman Res Inst, Duarte, CA USA
[3] City Hope Natl Med Ctr, Div Informat Sci, Duarte, CA 91010 USA
[4] City Hope Natl Med Ctr, Div Mol Biol, Duarte, CA 91010 USA
关键词
killer Ig-like receptor; KIR genotyping; hematopoietic cell transplantation; acute GVHD;
D O I
10.1038/sj.bmt.1705089
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Killer Ig-like receptor (KIR) is a major cluster of the natural killer cell receptors and may play a role in the outcome of hematopoietic cell transplants. A total of 65 AML cases transplanted with T-replete hematopoietic cells from unrelated donors were retrospectively KIR-genotyped by a multiplex PCR method of our own design. The KIR gene frequency and genotype patterns in these 130 samples were consistent with the data in the literature. Based upon overall inhibitory and activating KIR genes in both donors and patients, we developed an algorithm to calculate a compatibility score for each transplant case as plus, zero or minus. Significantly higher incidence (18/20, 90%) of acute ( a) GVHD ( grade II-IV) was found in the transplant cases with plus scores than that (25/45, 56%) in the cases with zero or minus scores ( P < 0.01). When the scores are sorted in the opposite way, fewer cases (13/26, 50%) of aGVHD were found in the transplants with minus scores than that (30/39, 77%) in the transplants with zero or plus scores ( P < 0.05). The difference of aGVHD prevalence between the plus score and minus score groups is highly significant ( P < 0.01). KIR genotype compatibility calculated by this algorithm may predict aGVHD incidence and be helpful in choosing donors.
引用
收藏
页码:525 / 530
页数:6
相关论文
共 38 条
[1]   A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia [J].
Arnheim, L ;
Dillner, J ;
Sanjeevi, CB .
TISSUE ANTIGENS, 2005, 65 (03) :252-259
[2]   Activation of natural killer cells:: Underlying molecular mechanisms revealed [J].
Backström, E ;
Kristensson, K ;
Ljunggren, HG .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2004, 60 (1-2) :14-22
[3]   The immunobiology of natural killer cells and bone marrow allograft rejection [J].
Barao, I ;
Murphy, WJ .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (12) :727-741
[4]   Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias [J].
Beelen, DW ;
Ottinger, HD ;
Ferencik, S ;
Elmaagacli, AH ;
Peceny, R ;
Trenschel, R ;
Grosse-Wilde, H .
BLOOD, 2005, 105 (06) :2594-2600
[5]   The beneficial role of inhibitory KIR genes of HLA class INK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD [J].
Bishara, A ;
De Santis, D ;
Witt, CC ;
Brautbar, C ;
Christiansen, FT ;
Or, R ;
Nagler, A ;
Slavin, S .
TISSUE ANTIGENS, 2004, 63 (03) :204-211
[6]   Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors [J].
Bornhäuser, M ;
Schwerdtfeger, R ;
Martin, H ;
Frank, KH ;
Theuser, C ;
Ehninger, G .
BLOOD, 2004, 103 (07) :2860-2861
[7]   Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells [J].
Borrego, F ;
Kabat, J ;
Kim, DK ;
Lieto, L ;
Maasho, K ;
Peña, J ;
Solana, R ;
Coligan, JE .
MOLECULAR IMMUNOLOGY, 2002, 38 (09) :637-660
[8]  
Carrington M., 2003, The KIR Gene Cluster
[9]   Shaping of adaptive immunity by innate interactions [J].
Castriconi, R ;
Della Chiesa, M ;
Moretta, A .
COMPTES RENDUS BIOLOGIES, 2004, 327 (06) :533-537
[10]   Transplant donor KIR genotype influences the rate of CMV reactivation following T-replete stem cell transplantation. [J].
Cook, M ;
Briggs, DC ;
Craddock, CF ;
Mahendra, P ;
Milligan, D ;
Fegan, C ;
Darbyshire, P ;
Lawson, S ;
Boxall, E ;
Moss, P .
BLOOD, 2004, 104 (11) :58A-58A